Suppr超能文献

CBASS 噬菌体防御与抗病毒核苷酸信号转导的进化

CBASS phage defense and evolution of antiviral nucleotide signaling.

机构信息

Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, MA 02115, USA.

出版信息

Curr Opin Immunol. 2022 Feb;74:156-163. doi: 10.1016/j.coi.2022.01.002. Epub 2022 Feb 2.

Abstract

Cyclic oligonucleotide-based antiphage signaling system (CBASS) immunity is a widespread form of antiphage defense in bacteria and archaea. Each CBASS operon encodes a cGAS/DncV-like Nucleotidyltransferase (CD-NTase) enzyme that synthesizes a nucleotide second messenger in response to viral infection. An associated Cap effector protein then binds the nucleotide signal and executes cell death to destroy the host cell and block phage propagation. Here we build upon recent advances to establish rules controlling each step of CBASS activation and antiphage defense. Comparative analysis of CBASS, CRISPR, Pycsar, and cGAS-STING immunity provides insight into the evolution of phage defense and animal innate immunity and highlights new questions emerging in the role of nucleotide second messenger signaling in host-virus interactions.

摘要

环状寡核苷酸为基础的抗噬菌体信号系统 (CBASS) 免疫是细菌和古菌中广泛存在的一种抗噬菌体防御机制。每个 CBASS 操纵子编码一种 cGAS/DncV 样核苷酸转移酶 (CD-NTase) 酶,该酶在病毒感染时合成核苷酸第二信使。然后,一种相关的 Cap 效应蛋白结合核苷酸信号并执行细胞死亡,以破坏宿主细胞并阻止噬菌体的传播。在这里,我们基于最近的进展,建立了控制 CBASS 激活和抗噬菌体防御的每一步的规则。对 CBASS、CRISPR、Pycsar 和 cGAS-STING 免疫的比较分析,深入了解了噬菌体防御和动物先天免疫的进化,并突出了在宿主-病毒相互作用中核苷酸第二信使信号的作用所出现的新问题。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验